Approved for the prevention of surgical site infections
On the 3 February, the National Institute for Health and Care Excellence (NICE) Medical Technologies Advisory Committee approved the use of Leukomed Sorbact (Essity, UK) for the prevention of surgical site infections. The dressing works by binding bacteria to the dressing itself, which is then removed at dressing change. Approval was given for two indications, post-caesarean section or vascular surgery, for closed wounds where low-to-moderate exudate is expected. Cost modelling suggests a saving of £107 per person after caesarean section and £18 per person after vascular surgery.
The full details of the NICE recommendation can be found at https://www.nice.org.uk/guidance/mtg55/chapter/2-The-technology
